A validated mathematical model of FGFR3‐mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer
Author:
Affiliation:
1. Applied BioMath LLC Concord Massachusetts USA
2. Department of Mathematics University of Michigan Ann Arbor Michigan USA
3. Section of Hematology/Oncology Department of Medicine The University of Chicago Chicago Illinois USA
Funder
National Institutes of Health
Publisher
Wiley
Subject
Industrial and Manufacturing Engineering,Polymers and Plastics,Business and International Management
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cso2.1019
Reference51 articles.
1. Cancer statistics, 2020
2. Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years
3. Progress in Personalizing Chemotherapy for Bladder Cancer
4. Targeted therapies for advanced bladder cancer: New strategies with FGFR inhibitors;Casadei C.;Ther. Adv. Med. Oncol.,2019
5. A multimodal imaging approach for longitudinal evaluation of bladder tumor development in an orthotopic murine model;Sheepbouwer C.;PLoS ONE,2016
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers;International Journal of Molecular Sciences;2024-01-10
2. Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms;Scientific Reports;2023-12-18
3. Mathematical Modeling Support for Lung Cancer Therapy—A Short Review;International Journal of Molecular Sciences;2023-09-25
4. Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies;ACS Pharmacology & Translational Science;2023-04-18
5. Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment;Molecular Cancer;2023-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3